US EditionFDA OKs trial of pig livers as dialysis-like treatment for liver failure
- U.S. Researchers will test whether livers from a gene-edited pig could treat people with sudden liver failure by filtering their blood temporarily so their own organ can rest and heal, according to the Food and Drug Administration.
- The Food and Drug Administration has cleared the first-of-its-kind clinical trial to study this treatment approach.
- The trial will enroll up to 20 patients who are in intensive-care units and are not suitable for liver transplants.
- In previous experiments, the pig liver supported some human liver functions for two to three days, according to Mike Curtis, CEO of eGenesis.
45 Articles
45 Articles
Pig liver transplant (genetically modified) on human patients, FDA green light for first clinical trial
The xenograft trial will involve 4 patients and will serve to verify if the genetically modified pig liver can be used safely to treat patients with severe organ failure. If the outcome is positive, the idea is to treat up to 20 patients
Rockdale Citizen & Newton Citizen
Clayton NewsNew Trial Will Test Gene-Edited Pig Liver for Sudden Liver Failure Patients
Key Takeaways
Pig organ transplants take speed: green light to the first multiple trials with humans
The US authorities have just approved the first clinical trial with pig livers to treat four people with severe liver failure, which is in addition to the first multiple trial with pig kidneys authorized in February, a milestone in this field The first pig liver transplant to a human opens a way to expand the stock of available organs The FDA, the body regulating drugs in the US, has approved the first clinical trial to assess the safety of the …
FDA approves pig liver trial as dialysis-like treatment for hepatic impairment
American researchers will soon test whether the livers of a genetically edited pig could treat people with sudden liver failure, temporarily filtering their blood so that their own organ can rest and perhaps heal. The clinical trial, the first of its kind, has been approved by the Food and Drug Administration, according to the eGenesis pig producer, who announced the measure on Tuesday with his partner OrganOx. It is estimated that 35,000 people…
Can a Pig Liver Give a Human Liver Time to Heal?
What if gene-edited pig livers could hold the key to saving thousands of human lives each year? A groundbreaking clinical trial aims to find out. The FDA has given the green light to the trial, which will test gene-edited pig livers as a treatment for sudden liver failure. The AP...
FDA Approves First Trial to Transplant Genetically Modified Pig Livers to Humans
FDA gives green light for transplant trial using pig livers. Credit: Marji Beach / CC BY-NC-ND 2.0 The U.S. Food and Drug Administration (FDA) has approved the first clinical trial to transplant genetically modified pig livers into human patients to test whether they can safely support people suffering from severe liver failure, a decision researchers are hailing as a landmark in animal-to-human organ support. The trial involves using pig livers…
Coverage Details
Bias Distribution
- 56% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
